These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 2483573)
41. The role of multiple action agents in hypertension. Lund-Johansen P; Omvik P Eur J Clin Pharmacol; 1990; 38 Suppl 2():S89-95. PubMed ID: 1974512 [TBL] [Abstract][Full Text] [Related]
42. alpha-Methyldopa and beta-blockers in hypertension--a comparison of their haemodynamic effects. Lund-Johansen P Clin Exp Pharmacol Physiol Suppl; 1978; 4():23-34. PubMed ID: 28190 [TBL] [Abstract][Full Text] [Related]
43. Increased cardiovascular responses to norepinephrine and calcium antagonists in essential hypertension compared with normotension in humans. Aoki K; Sato K; Kawaguchi Y J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S182-6. PubMed ID: 2414585 [TBL] [Abstract][Full Text] [Related]
44. Long-term haemodynamic effects of amlodipine at rest and during exercise in essential hypertension. Lund-Johansen P; Omvik P; White W; Digranes O; Helland B; Jordal O; Stray T J Hypertens; 1990 Dec; 8(12):1129-36. PubMed ID: 1962802 [TBL] [Abstract][Full Text] [Related]
45. Acute and chronic haemodynamic effects of doxazosin in hypertension at rest and during exercise. Lund-Johansen P; Omvik P; Haugland H Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):45S-54S. PubMed ID: 2939867 [TBL] [Abstract][Full Text] [Related]
46. Acute and chronic hemodynamic effects of drugs with different actions on adrenergic receptors: a comparison between alpha blockers and different types of beta blockers with and without vasodilating effect. Lund-Johansen P; Omvik P Cardiovasc Drugs Ther; 1991 Jun; 5(3):605-15. PubMed ID: 1678963 [TBL] [Abstract][Full Text] [Related]
47. Haemodynamic long-term effects of beta-receptor-blocking agents in hypertension: a comparison between alprenolol, atenolol, metoprolol and timolol. Lund-Johansen P; Ohm OJ Clin Sci Mol Med Suppl; 1976 Dec; 3():481S-483S. PubMed ID: 15759 [TBL] [Abstract][Full Text] [Related]
48. Central hemodynamic changes of calcium antagonists at rest and during exercise in essential hypertension. Lund-Johansen P; Omvik P J Cardiovasc Pharmacol; 1987; 10 Suppl 1():S139-48. PubMed ID: 2442506 [TBL] [Abstract][Full Text] [Related]
49. [Cardiac output studied by a non invasive method in hypertensive patients]. Balansard P; Poggi JN; Gonzalez T; Michel C; Baralla A; Aidibe A; Raufast D Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1075-8. PubMed ID: 1482236 [TBL] [Abstract][Full Text] [Related]
50. Central haemodynamic effects of beta blockers in hypertension. A comparison between atenolol, metoprolol, timolol, penbutolol, alprenolol pindolol and bunitrolol. Lund-Johansen P Eur Heart J; 1983 Jul; 4 Suppl D():1-12. PubMed ID: 6137366 [TBL] [Abstract][Full Text] [Related]
51. Acute and long-term hemodynamic effects of tiapamil at rest and during exercise in essential hypertension. Omvik P; Lund-Johansen P Cardiovasc Drugs Ther; 1989 Aug; 3(4):517-23. PubMed ID: 2488103 [TBL] [Abstract][Full Text] [Related]
52. Twenty-year follow-up of hemodynamics in essential hypertension during rest and exercise. Lund-Johansen P Hypertension; 1991 Nov; 18(5 Suppl):III54-61. PubMed ID: 1937687 [TBL] [Abstract][Full Text] [Related]
53. Possible significance of the pharmacological differentiation of beta-blocking agents in hemodynamic effects in essential hypertension. Tsukiyama H; Otsuka K; Horii M; Yoshii Y; Hatori Y; Nakamura Y; Nemoto E; Yamato T; Sakai T; Yamamoto Y Jpn Circ J; 1983 Mar; 47(3):313-22. PubMed ID: 6132016 [TBL] [Abstract][Full Text] [Related]
54. Exercise and antihypertensive therapy. Lund-Johansen P Am J Cardiol; 1987 Jan; 59(2):98A-107A. PubMed ID: 2880493 [TBL] [Abstract][Full Text] [Related]
55. Hemodynamic changes in hypertensive patients at rest and during physical exercise before and after acute i.v. administration of bufuralol-HCl or propranolol. Magometschnigg D; Bonelli J; Kaik G; Rameis H Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):334-40. PubMed ID: 39899 [TBL] [Abstract][Full Text] [Related]
56. Haemodynamic consequences of intrinsic sympathomimetic activity and cardioselectivity in beta-blocker therapy for hypertension. Man in 't Veld AJ; Schalekamp MA Eur Heart J; 1983 Jul; 4 Suppl D():31-41. PubMed ID: 6137381 [TBL] [Abstract][Full Text] [Related]
57. Combined captopril and hydrochlorothiazide therapy in severe hypertension: long-term haemodynamic changes at rest and during exercise. Omvik P; Lund-Johansen P J Hypertens; 1984 Feb; 2(1):73-80. PubMed ID: 6397525 [TBL] [Abstract][Full Text] [Related]
58. Effect of beta-blockers on exercise physiology: implications for exercise training. Gordon NF; Duncan JJ Med Sci Sports Exerc; 1991 Jun; 23(6):668-76. PubMed ID: 1679517 [TBL] [Abstract][Full Text] [Related]
59. Baroreflex sensitivity and the blood pressure response to beta-blockade. Chen X; Hassan MO; Jones JV; Sleight P; Floras JS J Hum Hypertens; 1999 Mar; 13(3):185-90. PubMed ID: 10204815 [TBL] [Abstract][Full Text] [Related]